Fields »
ABOUT
HELP
BLOG

126 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 3 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles		Mixed
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneMixed
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCC8ATP-binding cassette, sub-family C (CFTR/MRP), member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol		Tissue enhanced
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
ADORA2AAdenosine A2a receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolMixed
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol		Tissue enriched
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Golgi apparatusExpressed in all
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
VesiclesExpressed in all
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Vesicles		Tissue enhanced
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Vesicles		Tissue enhanced
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
CACNB2Calcium channel, voltage-dependent, beta 2 subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Mixed
CACNB3Calcium channel, voltage-dependent, beta 3 subunitFDA approved drug targets
Predicted intracellular proteins
Transporters
Golgi apparatus
Vesicles		Mixed
CACNB4Calcium channel, voltage-dependent, beta 4 subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Tissue enhanced
CACNG1Calcium channel, voltage-dependent, gamma subunit 1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CAMLGCalcium modulating ligandFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Nucleoli
Vesicles		Expressed in all
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA4Cholinergic receptor, nicotinic, alpha 4 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNA7Cholinergic receptor, nicotinic, alpha 7 (neuronal)FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
CHRNB2Cholinergic receptor, nicotinic, beta 2 (neuronal)Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CLCN2Chloride channel, voltage-sensitive 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
CytosolMixed
CNR1Cannabinoid receptor 1 (brain)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membrane
Actin filaments		Tissue enhanced
CYSLTR1Cysteinyl leukotriene receptor 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
DRD2Dopamine receptor D2FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enriched
DRD3Dopamine receptor D3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
ERBB4Erb-b2 receptor tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
FSHRFollicle stimulating hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Group enriched
FXYD2FXYD domain containing ion transport regulator 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
MitochondriaGroup enriched
GABBR2Gamma-aminobutyric acid (GABA) B receptor, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
GABRA1Gamma-aminobutyric acid (GABA) A receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRA2Gamma-aminobutyric acid (GABA) A receptor, alpha 2FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enriched
GABRB2Gamma-aminobutyric acid (GABA) A receptor, beta 2FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GABRB3Gamma-aminobutyric acid (GABA) A receptor, beta 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enhanced
GABRG2Gamma-aminobutyric acid (GABA) A receptor, gamma 2Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
GHRHRGrowth hormone releasing hormone receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Not detected
GLP1RGlucagon-like peptide 1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
GLRA1Glycine receptor, alpha 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
GLRA2Glycine receptor, alpha 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched

Page of 3 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.